Teva Announces Collaboration to Commercialize Formycon’s Biosimilar Candidate to Eylea® (aflibercept) in major parts of Europe and in Israel Notified -
Cority Recognized as a Leader in Independent Analyst Firm’s Green Quadrant EHS Software 2025 Report Notified -
Philips appoints Jie Xue as Chief Business Leader Precision Diagnosis, co-leader of the Diagnosis & Treatment segment, and Özlem Fidanci as Chief of International Region Notified -